GSK to take $3.4 bln Avandia legal charge
Monday, January 17, 2011 - 11:31
in Mathematics & Economics
British drugs firm GlaxoSmithKline said Monday it expects to take a legal charge of £2.2 billion linked to its former blockbuster diabetes product Avandia, sparking a sharp drop in its shares.
